CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 178 filers reported holding CRISPR THERAPEUTICS AG in Q1 2019. The put-call ratio across all filers is 1.73 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $81,652,000 | +6210.0% | 1,077,483 | +3431.6% | 2.60% | +1827.4% |
| Q1 2020 | $1,294,000 | -98.3% | 30,510 | -98.1% | 0.14% | -98.2% |
| Q2 2019 | $75,843,000 | +13.0% | 1,610,250 | -14.3% | 7.66% | +23.9% |
| Q1 2019 | $67,092,000 | +1024.4% | 1,878,277 | +799.3% | 6.18% | +936.0% |
| Q4 2018 | $5,967,000 | -73.1% | 208,850 | -58.2% | 0.60% | -70.1% |
| Q3 2018 | $22,175,000 | – | 500,000 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,608,874 | $160,053,562,000 | 54.44% |
| Abingworth LLP | 1,237,202 | $54,858,000 | 32.62% |
| NEA Management Company, LLC | 2,090,678 | $92,722,000 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 444,708 | $19,723,000 | 3.59% |
| EcoR1 Capital, LLC | 500,000 | $22,175,000 | 2.00% |
| ARK Investment Management | 1,453,590 | $64,467,000 | 1.95% |
| CLOUGH CAPITAL PARTNERS L P | 337,731 | $14,978,000 | 1.41% |
| Casdin Capital, LLC | 220,000 | $9,757,000 | 1.19% |
| Valiant Capital Management, L.P. | 271,700 | $12,050,000 | 1.07% |
| Monashee Investment Management LLC | 110,000 | $4,879,000 | 1.03% |